The Washington Times: Medicare payments for brand-name drugs spiked from 2011 to 2015 even as doctors wrote fewer prescriptions for them, according to a federal report Monday that says soaring manufacturer prices are taking a toll on taxpayers and seniors.
The Health and Human Services Department’s inspector general said total reimbursements under Medicare’s drug benefit, or Part D, for all brand-name drugs increased 77 percent — from $58 billion to $102 billion — while prescriptions dropped by 17 percent, from 229 million in 2011 to 191 million to 2015.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now